CRISPR research has already begun in somatic (non-reproductive) cells. “The earliest ones are going to be somatic interventions with various kinds of blood stem cells,” Pilar Ossorio, professor of law and bioethics at the Morgridge Institute for Research at the University of Wisconsin-Madison, told CBS News at the gene editing summit in Washington, DC.
Office of Strategic Communication